Aster Whitefield Hospital Introduces Intra-Operative Electron Radiation Therapy (IOeRT)

This advanced technology targets cancer cells during surgery, offering patients fewer post-operative radiation sessions and potentially reducing recovery times.

Aster Whitefield Hospital, Bengaluru, has introduced Intra-Operative Electron Radiation Therapy (IOeRT) at its Aster International Institute of Oncology (AIIO). This advanced technology targets cancer cells during surgery, offering patients fewer post-operative radiation sessions and potentially reducing recovery times. 

This development aligns with India’s increasing demand for more efficient cancer care, as the country is projected to face a 57.5% rise in cancer cases by 2040, according to the GLOBOCAN report.

Targeted Radiation for Improved Patient Outcomes

IOeRT allows direct delivery of concentrated radiation to the tumor site during surgery. This approach minimizes the need for multiple radiation sessions after surgery and helps protect surrounding healthy tissues. By targeting the remaining microscopic cancer cells immediately after tumor removal, IOeRT increases the chances of successful treatment while reducing the risk of recurrence. It is especially beneficial for treating complex breast, gastrointestinal, and lung cancers.

Alisha Moopen, Deputy Managing Director of Aster DM Healthcare, commented on the significance of this advancement, saying, "By integrating this advanced technology, our hospital is stepping into a new frontier of precision oncology. We aim to offer more targeted, effective, and less invasive treatments, enabling faster patient recovery. Our goal is to set new standards for treatment protocols, giving patients access to the most sophisticated tools and techniques globally. This integration will improve treatment quality and help patients return to normal life more quickly.”

A New Hope for Advanced Cancers

Dr. Somashekhar SP, Global Director of Aster International Institute of Oncology, emphasized the role of IOeRT in treating complex and advanced cancers. 

He stated, "With IOeRT, we can offer new hope to patients facing cancers where conventional treatments often fall short. This technology allows us to target residual cancer cells with unparalleled accuracy, leading to fewer side effects and better recovery outcomes. It’s a breakthrough that is set to significantly impact cancer care by reducing recurrence rates and improving long-term results."

As part of its comprehensive cancer care, Aster Whitefield Hospital’s team of experienced surgeons, radiation oncologists, and support staff will provide a personalized treatment approach, using this new technology to improve patient care.

Francesco Zanetti, President & CEO of SIT, also commented on the potential impact of IOeRT in India, stating, "This equipment will empower oncologists in India to provide more effective, personalized treatments, improving survival rates and overall quality of care."